home / stock / adma / adma short
Short Information | ADMA Biologics Inc (NASDAQ:ADMA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 7,062,766 |
Total Actual Volume | 64,722,862 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 353,138 |
Average Short Percentage | 11.34% |
Is there a ADMA Short Squeeze or Breakout about to happen?
See the ADMA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-15-2024 | $5.98 | $5.99 | $6.08 | $5.89 | 3,750,695 | 178,540 | 4.76% |
03-14-2024 | $6.2 | $6.02 | $6.25 | $6.01 | 3,001,858 | 478,288 | 15.93% |
03-13-2024 | $6.23 | $6.26 | $6.27 | $6.13 | 2,521,921 | 471,972 | 18.71% |
03-12-2024 | $6.19 | $6.22 | $6.36 | $6.12 | 2,497,964 | 181,784 | 7.28% |
03-11-2024 | $6.34 | $6.18 | $6.34 | $6.1 | 3,029,575 | 471,860 | 15.58% |
03-08-2024 | $6.21 | $6.34 | $6.415 | $6.21 | 3,093,435 | 316,764 | 10.24% |
03-07-2024 | $6.18 | $6.16 | $6.41 | $6.095 | 6,994,985 | 772,735 | 11.05% |
03-06-2024 | $5.84 | $6.12 | $6.19 | $5.705 | 7,943,594 | 808,791 | 10.18% |
03-05-2024 | $5.7 | $5.8 | $5.82 | $5.685 | 2,253,637 | 343,463 | 15.24% |
03-04-2024 | $5.59 | $5.72 | $5.805 | $5.52 | 2,589,078 | 264,166 | 10.2% |
03-01-2024 | $5.38 | $5.52 | $5.565 | $5.315 | 3,588,475 | 244,319 | 6.81% |
02-29-2024 | $5.38 | $5.36 | $5.72 | $5.08 | 6,327,016 | 580,924 | 9.18% |
02-28-2024 | $5.53 | $5.38 | $5.53 | $5.36 | 3,291,328 | 432,663 | 13.15% |
02-27-2024 | $5.44 | $5.52 | $5.58 | $5.415 | 2,671,799 | 305,736 | 11.44% |
02-26-2024 | $5.25 | $5.4 | $5.44 | $5.205 | 1,950,533 | 199,171 | 10.21% |
02-23-2024 | $5.26 | $5.26 | $5.28 | $5.1701 | 1,261,123 | 187,540 | 14.87% |
02-22-2024 | $5.19 | $5.26 | $5.32 | $5.16 | 1,838,534 | 224,441 | 12.21% |
02-21-2024 | $5.13 | $5.18 | $5.26 | $5.02 | 2,050,988 | 168,855 | 8.23% |
02-20-2024 | $5.23 | $5.15 | $5.28 | $5.11 | 1,780,782 | 218,554 | 12.27% |
02-16-2024 | $5.38 | $5.28 | $5.41 | $5.27 | 2,285,542 | 212,200 | 9.28% |
News, Short Squeeze, Breakout and More Instantly...
FDA Approval Provides for Room Temperature (25°C) Storage Conditions for up to 4 Weeks at Any Point During the 36-Month Approved Shelf Life Extends the Prior Room Temperature Storage Allowance for the Full 36-months for ASCENIV and BIVIGAM Provides for Improved Inventory Ma...
RAMSEY, N.J. and BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA) ("ADMA" or the "Company"), an end-to-en...
RAMSEY, N.J. and BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, today anno...